Home/Filings/4/A/0001839066-25-000007
4/A//SEC Filing

Reynoso Jamie L. 4/A

Accession 0001839066-25-000007

CIK 0001801170other

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 5:00 PM ET

Size

5.9 KB

Accession

0001839066-25-000007

Insider Transaction Report

Form 4/AAmended
Period: 2024-09-13
Reynoso Jamie L.
CEO, Medicare Advantage
Transactions
  • Award

    Class A Common Stock

    2024-09-13+518,0002,531,545 total
Footnotes (2)
  • [F1]Represents restricted stock units ("RSUs"), each representing a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units will vest on October 31, 2025, subject to the Reporting Person's continued employment on such vesting date. This Amendment is being filed solely to reflect the full number of RSUs that were achieved.
  • [F2]Number reflects total directly held Class A Common Stock taking into account the amended number and subsequent transactions through September 15, 2024.

Issuer

CLOVER HEALTH INVESTMENTS, CORP. /DE

CIK 0001801170

Entity typeother

Related Parties

1
  • filerCIK 0001839066

Filing Metadata

Form type
4/A
Filed
Sep 15, 8:00 PM ET
Accepted
Sep 16, 5:00 PM ET
Size
5.9 KB